About this item:

706 Views | 243 Downloads

Author Notes:

Both authors have contributed equally to this manuscript.

Contributor Information Andrew G. Lee, Chair, Department of Ophthalmology, The Methodist Hospital, Houston, TX; Professor of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medical College; Adjunct Professor of Ophthalmology, The University of Iowa Hospitals and Clinics; Clinical Professor of Ophthalmology, UTMB, Galveston, TX, Department of Ophthalmology, The Methodist Hospital, 6560 Fannin Street, Scurlock 2100, Houston, Texas 77030, 713-441-8823.

Subjects:

Research Funding:

This study was supported in part by a departmental grant (Department of Ophthalmology, Emory University) from Research to Prevent Blindness, Inc, New York, New York, and by core grant P30-EY06360 (Department of Ophthalmology) from the National Institute of Health, Bethesda, Maryland.

Keywords:

  • Nonarteritic anterior optic neuropathy
  • steroids
  • intravitreal injections
  • treatment

Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy (NAION)?

Tools:

Journal Title:

Journal of Neuro-Ophthalmology

Volume:

Volume 30, Number 2

Publisher:

, Pages 193-198

Type of Work:

Article | Post-print: After Peer Review

Abstract:

The treatment of nonarteritic anterior optic neuropathy remains very limited and disappointing. Recent publications have suggested that oral steroids as well as intravitreal injections of steroids might be helpful to accelerate resolution of disc edema and improve visual outcome. However, the use of steroids to treat acute NAION remains largely debated.

Copyright information:

© North American Neuro-ophthalmology Society

Export to EndNote